These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34118451)

  • 1. Harnessing biomaterials for lymphatic system modulation.
    Alderfer L; Hall E; Hanjaya-Putra D
    Acta Biomater; 2021 Oct; 133():34-45. PubMed ID: 34118451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomaterial Based Strategies for Engineering New Lymphatic Vasculature.
    Campbell KT; Silva EA
    Adv Healthc Mater; 2020 Sep; 9(18):e2000895. PubMed ID: 32734721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic Regulation in Tissue Repair and Regeneration: Recent Advances and Future Perspective.
    Bei Y; Liu J; Xiao J
    Curr Stem Cell Res Ther; 2023; 18(6):730-732. PubMed ID: 35674310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lymphatic System in Disease Processes and Cancer Progression.
    Padera TP; Meijer EF; Munn LL
    Annu Rev Biomed Eng; 2016 Jul; 18():125-58. PubMed ID: 26863922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic system identification, pathophysiology and therapy in the cardiovascular diseases.
    Hu D; Li L; Li S; Wu M; Ge N; Cui Y; Lian Z; Song J; Chen H
    J Mol Cell Cardiol; 2019 Aug; 133():99-111. PubMed ID: 31181226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomaterials for Modulating Lymphatic Function in Immunoengineering.
    Sestito LF; Thomas SN
    ACS Pharmacol Transl Sci; 2019 Oct; 2(5):293-310. PubMed ID: 32259064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-of-the-art drug delivery system to target the lymphatics.
    Khaire OT; Mhaske A; Prasad AG; Almalki WH; Srivastava N; Kesharwani P; Shukla R
    J Drug Target; 2024 Apr; 32(4):347-364. PubMed ID: 38253594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?
    Abouelkheir GR; Upchurch BD; Rutkowski JM
    Exp Biol Med (Maywood); 2017 Apr; 242(8):884-895. PubMed ID: 28346012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
    Trevaskis NL; Kaminskas LM; Porter CJ
    Nat Rev Drug Discov; 2015 Nov; 14(11):781-803. PubMed ID: 26471369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between lymphangiogenesis and angiogenesis during inflammation in rat mesentery microvascular networks.
    Sweat RS; Stapor PC; Murfee WL
    Lymphat Res Biol; 2012 Dec; 10(4):198-207. PubMed ID: 23240958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangiogenesis in development and disease.
    Mäkinen T; Alitalo K
    Novartis Found Symp; 2007; 283():87-98; discussion 98-105, 238-41. PubMed ID: 18300416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer treatment in the lymphatic system: A prospective targeting employing nanostructured systems.
    Yukuyama MN; de Araujo GLB; de Souza A; Löbenberg R; Barbosa EJ; Henostroza MAB; Rocha NPD; de Oliveira IF; Folchini BR; Peroni CM; Masiero JF; Bou-Chacra NA
    Int J Pharm; 2020 Sep; 587():119697. PubMed ID: 32750440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis, inflammation and metastasis.
    Schoppmann SF
    Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering.
    Zhong JX; Raghavan P; Desai TA
    Regen Eng Transl Med; 2023; 9(2):224-239. PubMed ID: 37333620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of biomaterials for immunosuppression in tissue repair and regeneration.
    Shen P; Chen Y; Luo S; Fan Z; Wang J; Chang J; Deng J
    Acta Biomater; 2021 May; 126():31-44. PubMed ID: 33722787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic targeting by albumin-hitchhiking: Applications and optimisation.
    Abdallah M; Müllertz OO; Styles IK; Mörsdorf A; Quinn JF; Whittaker MR; Trevaskis NL
    J Control Release; 2020 Nov; 327():117-128. PubMed ID: 32771478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-induced lymphangiogenesis and lymphatic dysfunction.
    Liao S; von der Weid PY
    Angiogenesis; 2014 Apr; 17(2):325-34. PubMed ID: 24449090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lymphatic system in health and disease.
    Cueni LN; Detmar M
    Lymphat Res Biol; 2008; 6(3-4):109-22. PubMed ID: 19093783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating lymphangiogenesis in vitro and in vivo using engineered human lymphatic vessel networks.
    Landau S; Newman A; Edri S; Michael I; Ben-Shaul S; Shandalov Y; Ben-Arye T; Kaur P; Zheng MH; Levenberg S
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting tissue regeneration by modulating the immune system.
    Julier Z; Park AJ; Briquez PS; Martino MM
    Acta Biomater; 2017 Apr; 53():13-28. PubMed ID: 28119112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.